UK markets open in 4 hours 13 minutes

CMG Pharmaceutical Co., Ltd. (058820.KQ)

KOSDAQ - KOSDAQ Delayed price. Currency in KRW
Add to watchlist
2,080.000.00 (0.00%)
At close: 03:30PM KST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
93,766,403
93,906,675
82,197,410
69,475,496
64,459,891
Cost of revenue
50,465,922
50,203,948
41,295,950
36,024,850
33,249,439
Gross profit
43,300,482
43,702,727
40,901,460
33,450,645
31,210,452
Operating expenses
Research development
-
2,180,869
3,311,509
3,261,605
3,089,681
Selling general and administrative
24,555,424
18,858,521
17,212,584
14,327,839
12,102,012
Total operating expenses
-
40,665,786
37,920,064
31,790,169
29,388,087
Operating income or loss
12,690,406
3,036,941
2,981,396
1,660,476
1,822,365
Interest expense
-
79,543
15,277
20,695
22,853
Income before tax
6,393,843
6,731,033
-1,255,097
3,549,107
568,837
Income tax expense
-
275,684
-866,957
383,622
353,841
Income from continuing operations
6,000,368
6,455,349
-388,140
3,165,485
214,996
Net income
6,000,368
6,455,349
-388,140
3,165,485
214,996
Net income available to common shareholders
6,000,368
6,455,349
-388,140
3,165,485
214,996
Basic EPS
35.00
46.00
-3.00
23.00
2.00
Diluted EPS
35.00
46.00
-3.00
23.00
2.00
Basic average shares
141,186
140,334
129,380
137,630
138,892
Diluted average shares
141,186
134,486
129,380
137,630
138,892